Managing Non-traumatic Rhabdomyolysis Rhabdomyolysis caused by non-traumatic reasons needs similar treatment
Toxicity has always been a hot area of drug research and development, but the complex structure of ADC drugs brings certain difficulties to drug design and development
Con esta aprobacin y el lanzamiento de un genrico de Saxenda, ofrecemos a los pacientes en EEUU el primer GLP-1 genrico enfocado en la prdida de peso, declar Ernie Richardsen, vicepresidente snior y director de genricos comerciales en EEUU de Teva
GLP-1s are most well studied for weight loss (obesity) and blood sugar control (type 2 diabetes)
Furthermore, the knockdown of Pelo or Hbs1 expression caused the reduced accumulation of viral proteins (Fig
Screening of therapeutic targets of L-carnitine Well-documented pharmacological targets of L-carnitine were obtained using the following databases: Drugbank, [] SuperPred, [] PharmMapper, [] Therapeutic Target Database, [] and Swiss Target Prediction